MedPath

HIROSHIMA UNIVERSITY HOSPITAL

🇯🇵Japan
Ownership
-
Established
2003-01-01
Employees
-
Market Cap
-
Website
http://www.hiroshima-u.ac.jp/en/hosp/

Clinical Trials

69

Active:0
Completed:55

Trial Phases

5 Phases

Phase 1:4
Phase 2:4
Phase 3:3
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (69 trials with phase data)• Click on a phase to view related trials

Not Applicable
57 (82.6%)
Phase 1
4 (5.8%)
Phase 2
4 (5.8%)
Phase 3
3 (4.3%)
Phase 4
1 (1.4%)

Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia

Phase 1
Recruiting
Conditions
Aggressive NK Cell Leukemia
Interventions
First Posted Date
2023-05-17
Last Posted Date
2025-04-30
Lead Sponsor
Hiroshima University Hospital
Target Recruit Count
7
Registration Number
NCT05863234
Locations
🇯🇵

Hiroshima University Hospital, Hiroshima, Japan

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.